Ciba Health Named to New York Digital Health 100 For Fourth Consecutive Year
DH100 recognizes the companies shaping the future of healthcare innovation in NY
NY, NY (February 3, 2026) –
For the fourth straight year, Ciba Health has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region.
The DH100 spotlights the companies driving healthcare forward through bold ideas and scalable solutions. The 2026 list includes 48 new companies addressing some of healthcare’s most complex challenges.
“Being named to the DH100 for a fourth year reflects the momentum we’ve maintained, and the growing global demand for a better way to prevent and reverse chronic disease,” said Dr. Innocent Clement, Founder and CEO of Ciba Health. “From type 2 diabetes and obesity to autoimmune and digestive conditions, we’ve been effective at scaling a root-cause, whole-person model that meets complexity with precision, and delivers outcomes that truly change lives.”
“The breadth and depth of companies named to this year’s DH100 reflect a clear market shift from experimentation to execution,” said Bunny Ellerin, co-founder and CEO of DHNY. “These companies are scaling solutions that improve outcomes while building enduring businesses, demonstrating how innovation at the intersection of care delivery, data, and trust is shaping the next generation of healthcare leaders.”
This recognition comes on the heels of Ciba Health being named one of Modern Healthcare’s Best in Business earlier in the month.
In 2025, Ciba Health’s outcomes were independently validated by the Validation Institute, confirming that its AI-powered, integrative care model improves health outcomes while meaningfully reducing healthcare costs across populations. The evaluation verified Ciba Health’s ability to prevent, manage, and reverse both common and complex chronic conditions including cardiometabolic disease, type 2 diabetes, obesity, autoimmune and digestive disorders, and mental health challenges.
Key validated outcomes within 12 months include:
- 90% of members reporting symptom improvement
- 85% reduction in overall medication use
- 44% reduction in annual prescription drug costs
- Average 3-point reduction in HbA1c
- $5.3M+ in prescription drug savings
- 1.18x ROI
- 80 Net Promoter Score (NPS), reflecting high member satisfaction
The Validation Institute also confirmed the impact of Ciba Health’s GLP-1 Step Down Program, the first nationally structured program designed to help members safely taper off GLP-1 medications while restoring metabolic health and preventing rebound weight gain. Members who completed the program achieved an average 30-pound weight loss, reduced GLP-1 use by 85%, and generated millions of dollars in prescription drug savings.
To download a copy of the 2026 New York Healthcare Innovation Report, please click here.
About Ciba Health
Ciba Health is a unified care platform powered by AI that prevents and reverses common, complex, and costly chronic diseases. Ciba Health simplifies chronic disease care delivery through precision health labs, predictive analytics, whole-person root-cause care, and personalized treatment plans that lead to sustainable health outcomes. We are helping members who have cardiometabolic conditions, type 2 diabetes, prediabetes, autoimmune conditions, digestive disorders, and mental health challenges reverse their symptoms by 90% and cut medication usage by 85%. Since 2020, we’ve helped employers, health plans, health systems, and providers improve the health of their populations and reduce costs.
About Digital Health New York (DHNY)
Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, DHNY seeks to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Its flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded.
